Business Description
Viva Biotech Holdings
NAICS : 541714
SIC : 2834
ISIN : KYG9390W1015
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.55 | |||||
Equity-to-Asset | 0.5 | |||||
Debt-to-Equity | 0.52 | |||||
Debt-to-EBITDA | 4.61 | |||||
Interest Coverage | 2 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 0.61 | |||||
Beneish M-Score | -2.69 | |||||
WACC vs ROIC |
Growth Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 30.2 | |||||
3-Year EPS without NRI Growth Rate | -19.8 | |||||
3-Year Book Growth Rate | -6.9 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 39.1 | |||||
9-Day RSI | 42.57 | |||||
14-Day RSI | 45.2 | |||||
6-1 Month Momentum % | 61.54 | |||||
12-1 Month Momentum % | -12.5 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.32 | |||||
Quick Ratio | 1.15 | |||||
Cash Ratio | 0.68 | |||||
Days Inventory | 80.59 | |||||
Days Sales Outstanding | 72.63 | |||||
Days Payable | 79.67 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -3.9 | |||||
Shareholder Yield % | 32.29 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 33.65 | |||||
Operating Margin % | 12.05 | |||||
Net Margin % | -0.11 | |||||
FCF Margin % | 0.15 | |||||
ROE % | -0.06 | |||||
ROA % | -0.03 | |||||
ROIC % | 0.99 | |||||
ROC (Joel Greenblatt) % | 9.63 | |||||
ROCE % | 3.86 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 0.86 | |||||
PB Ratio | 0.46 | |||||
Price-to-Tangible-Book | 1.53 | |||||
Price-to-Free-Cash-Flow | 435 | |||||
Price-to-Operating-Cash-Flow | 7.84 | |||||
EV-to-EBIT | 12.06 | |||||
EV-to-EBITDA | 6.12 | |||||
EV-to-Revenue | 1.28 | |||||
EV-to-FCF | 826.41 | |||||
Price-to-Projected-FCF | 1.47 | |||||
Price-to-Graham-Number | 0.78 | |||||
Earnings Yield (Greenblatt) % | 8.29 | |||||
FCF Yield % | 0.18 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Viva Biotech Holdings Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil HK$) | 2,165.405 | ||
EPS (TTM) (HK$) | -0.1 | ||
Beta | 1.72 | ||
Volatility % | 81.51 | ||
14-Day RSI | 45.2 | ||
14-Day ATR (HK$) | 0.042251 | ||
20-Day SMA (HK$) | 0.9025 | ||
12-1 Month Momentum % | -12.5 | ||
52-Week Range (HK$) | 0.41 - 1.22 | ||
Shares Outstanding (Mil) | 2,113.42 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Viva Biotech Holdings Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Viva Biotech Holdings Stock Events
Event | Date | Price(HK$) | ||
---|---|---|---|---|
No Event Data |
Viva Biotech Holdings Frequently Asked Questions
What is Viva Biotech Holdings(HKSE:01873)'s stock price today?
When is next earnings date of Viva Biotech Holdings(HKSE:01873)?
Does Viva Biotech Holdings(HKSE:01873) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |